Curaxys

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vrac (talk | contribs) at 19:54, 26 July 2015 (de-orphaned, rm unref tag). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Curaxys is a biopharmaceutical company specializing in the research, development and production of biosimilar (generic biological) drugs. Located in the Technological Park of Puerto de Santa Maria, in Cadiz, Spain, the company collaborates on research with the University of Cadiz.[1]

Curaxys has patented a process for producing insulin from plant cells as well as a process for developing cancer drugs from cultured human cells.[2]

References

  1. ^ Paloma, Libertad. "La biotecnología crea empleo para la Bahía de Cadiz". elpais.com. Ediciones El Pais S.L. Retrieved 26 July 2015.
  2. ^ Almendras El Puerto, Teresa. "Curaxys fabricará sus medicamentos biológicos en el Tecnoparque en 2016". diariodecadiz.es. Joly Digita. Retrieved 26 July 2015.